Literature DB >> 27062503

Mutations in the IRBIT domain of ITPR1 are a frequent cause of autosomal dominant nonprogressive congenital ataxia.

S Barresi1,2, M Niceta2, P Alfieri3, V Brankovic4, G Piccini3, A Bruselles5, M R Barone6, R Cusmai7, M Tartaglia2, E Bertini1, G Zanni1.   

Abstract

Congenital ataxias are nonprogressive neurological disorders characterized by neonatal hypotonia, developmental delay and ataxia, variably associated with intellectual disability and other neurological or extraneurological features. We performed trio-based whole-exome sequencing of 12 families with congenital cerebellar and/or vermis atrophy in parallel with targeted next-generation sequencing of known ataxia genes (CACNA1A, ITPR1, KCNC3, ATP2B3 and GRM1) in 12 additional patients with a similar phenotype. Novel pathological mutations of ITPR1 (inositol 1,4,5-trisphosphate receptor, type 1) were found in seven patients from four families (4/24, ∼16.8%) all localized in the IRBIT (inositol triphosphate receptor binding protein) domain which plays an essential role in the regulation of neuronal plasticity and development. Our study expands the mutational spectrum of ITPR1-related congenital ataxia and indicates that ITPR1 gene screening should be implemented in this subgroup of ataxias.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IRBIT domain; ITPR1; WES; cerebellar atrophy; congenital ataxia; targeted resequencing

Mesh:

Substances:

Year:  2016        PMID: 27062503     DOI: 10.1111/cge.12783

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  15 in total

1.  Inositol 1,4,5-trisphosphate Receptor Mutations associated with Human Disease.

Authors:  Lara E Terry; Kamil J Alzayady; Esraa Furati; David I Yule
Journal:  Messenger (Los Angel)       Date:  2018-06

Review 2.  Ion channel dysfunction in cerebellar ataxia.

Authors:  David D Bushart; Vikram G Shakkottai
Journal:  Neurosci Lett       Date:  2018-02-05       Impact factor: 3.046

3.  A novel gain-of-function mutation in the ITPR1 suppressor domain causes spinocerebellar ataxia with altered Ca2+ signal patterns.

Authors:  Jillian P Casey; Taisei Hirouchi; Chihiro Hisatsune; Bryan Lynch; Raymond Murphy; Aimee M Dunne; Akitoshi Miyamoto; Sean Ennis; Nick van der Spek; Bronagh O'Hici; Katsuhiko Mikoshiba; Sally Ann Lynch
Journal:  J Neurol       Date:  2017-06-15       Impact factor: 4.849

4.  De novo ITPR1 variants are a recurrent cause of early-onset ataxia, acting via loss of channel function.

Authors:  Matthis Synofzik; Katherine L Helbig; Florian Harmuth; Tine Deconinck; Pranoot Tanpaiboon; Bo Sun; Wenting Guo; Ruiwu Wang; Erika Palmaer; Sha Tang; G Bradley Schaefer; Janina Gburek-Augustat; Stephan Züchner; Ingeborg Krägeloh-Mann; Jonathan Baets; Peter de Jonghe; Peter Bauer; S R Wayne Chen; Ludger Schöls; Rebecca Schüle
Journal:  Eur J Hum Genet       Date:  2018-06-20       Impact factor: 4.246

5.  Superior Cerebellar Atrophy: An Imaging Clue to Diagnose ITPR1-Related Disorders.

Authors:  Romina Romaniello; Ludovica Pasca; Elena Panzeri; Fulvio D'Abrusco; Lorena Travaglini; Valentina Serpieri; Sabrina Signorini; Chiara Aiello; Enrico Bertini; Maria Teresa Bassi; Enza Maria Valente; Ginevra Zanni; Renato Borgatti; Filippo Arrigoni
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

6.  Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29.

Authors:  Hideaki Ando; Matsumi Hirose; Katsuhiko Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-14       Impact factor: 12.779

7.  Mutational analysis of ITPR1 in a Taiwanese cohort with cerebellar ataxias.

Authors:  Cheng-Tsung Hsiao; Yo-Tsen Liu; Yi-Chu Liao; Ting-Yi Hsu; Yi-Chung Lee; Bing-Wen Soong
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

Review 8.  Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxia.

Authors:  Jessica L Zambonin; Allison Bellomo; Hilla Ben-Pazi; David B Everman; Lee M Frazer; Michael T Geraghty; Amy D Harper; Julie R Jones; Benjamin Kamien; Kristin Kernohan; Mary Kay Koenig; Matthew Lines; Elizabeth Emma Palmer; Randal Richardson; Reeval Segel; Mark Tarnopolsky; Jason R Vanstone; Melissa Gibbons; Abigail Collins; Brent L Fogel; Tracy Dudding-Byth; Kym M Boycott
Journal:  Orphanet J Rare Dis       Date:  2017-06-28       Impact factor: 4.123

Review 9.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 10.  Inositol 1,4,5-Trisphosphate Receptors in Human Disease: A Comprehensive Update.

Authors:  Jessica Gambardella; Angela Lombardi; Marco Bruno Morelli; John Ferrara; Gaetano Santulli
Journal:  J Clin Med       Date:  2020-04-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.